Barclays PLC Novavax Inc Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Novavax Inc stock. As of the latest transaction made, Barclays PLC holds 709,579 shares of NVAX stock, worth $5.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

709,579

Previous 709,579 -0.0%

Holding current value

$5.72 Million

Previous $8.96 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$10.71 - $17.11 $3.23 Million - $5.16 Million	301,627 Added 73.94%	709,579 $8.96 Million
Q2 2024 Aug 14, 2024	BUY	$3.89 - $20.97 $601,106 - $3.24 Million	154,526 Added 60.97%	407,952 $5.16 Million
Q1 2024 May 15, 2024	SELL	$3.76 - $6.02 $2.14 Million - $3.42 Million	-568,250 Reduced 69.16%	253,426 $1.21 Million
Q4 2023 Feb 15, 2024	BUY	$4.8 - $7.67 $1.29 Million - $2.05 Million	267,886 Added 48.37%	821,676 $3.94 Million
Q3 2023 Nov 07, 2023	BUY	$6.81 - $9.74 $83,320 - $119,168	12,235 Added 2.26%	553,790 $4.01 Million
Q2 2023 Aug 03, 2023	BUY	$6.67 - $9.52 $490,958 - $700,738	73,607 Added 15.73%	541,555 $4.02 Million
Q1 2023 May 04, 2023	BUY	$5.76 - $12.48 $2,770 - $6,002	481 Added 0.1%	467,948 $3.24 Million
Q4 2022 Feb 13, 2023	BUY	$8.86 - $25.04 $1 Million - $2.84 Million	113,247 Added 31.97%	467,467 $4.81 Million
Q3 2022 Nov 03, 2022	BUY	$18.2 - $76.12 $3.78 Million - $15.8 Million	207,949 Added 142.17%	354,220 $6.45 Million
Q2 2022 Aug 12, 2022	SELL	$36.28 - $75.29 $1.93 Million - $4 Million	-53,122 Reduced 26.64%	146,271 $7.52 Million
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $614,948 - $1.26 Million	8,819 Added 4.63%	199,393 $14.7 Million
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $12 Million - $19.4 Million	89,148 Added 87.89%	190,574 $27.3 Million
Q3 2021 Nov 09, 2021	SELL	$177.8 - $270.58 $19 Million - $29 Million	-107,131 Reduced 51.37%	101,426 $21 Million
Q2 2021 Aug 13, 2021	BUY	$121.0 - $257.67 $14.5 Million - $30.9 Million	119,982 Added 135.46%	208,557 $44.3 Million
Q1 2021 May 13, 2021	BUY	$112.98 - $319.93 $1.3 Million - $3.69 Million	11,533 Added 14.97%	88,575 $16.1 Million
Q4 2020 Feb 11, 2021	SELL	$78.74 - $139.5 $53,228 - $94,302	-676 Reduced 0.87%	77,042 $8.59 Million
Q3 2020 Nov 12, 2020	SELL	$79.44 - $178.51 $745,385 - $1.67 Million	-9,383 Reduced 10.77%	77,718 $8.42 Million
Q2 2020 Aug 12, 2020	BUY	$13.86 - $83.61 $593,582 - $3.58 Million	42,827 Added 96.73%	87,101 $7.26 Million
Q1 2020 May 13, 2020	BUY	$3.93 - $16.0 $32,104 - $130,704	8,169 Added 22.63%	44,274 $602,000
Q4 2019 Feb 10, 2020	BUY	$3.69 - $5.22 $23,158 - $32,760	6,276 Added 21.04%	36,105 $144,000
Q3 2019 Nov 14, 2019	BUY	$4.02 - $7.84 $35,946 - $70,105	8,942 Added 42.81%	29,829 $150,000
Q2 2019 Aug 14, 2019	BUY	$4.93 - $12.2 $102,972 - $254,821	20,887 New	20,887 $123,000

Others Institutions Holding NVAX

# of Institutions

292

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $630M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account